Submit Deal

ARREPATH

HQ - Princeton

Summary

ArrePath is a biotechnology company combining the power of human intelligence with artificial intelligence and machine learning to discover and develop antibacterial drugs.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Kevin Krause
President and CEO
Diego Miralles
Chair of the Board of Directors

Sort

23 Jun 2025|United States|Biotechnology

Target: ARREPATH

Bidder: AB MAGNITUDE VENTURES

1 Service Providers

1 Target

3 Dealmakers

3 Target

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy